BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 20107311)

  • 1. Cyclin D3 is dispensable for human diffuse large B-cell lymphoma survival and growth: evidence for redundancy with cyclin E.
    Gumina MR; Xu C; Chiles TC
    Cell Cycle; 2010 Feb; 9(4):820-8. PubMed ID: 20107311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclins D3 and E go hand in hand with Cdk4/6 in diffuse large B-cell lymphoma.
    Gilmore TD; Thompson RC; Faber AC
    Cell Cycle; 2010 Feb; 9(3):448-9. PubMed ID: 20130454
    [No Abstract]   [Full Text] [Related]  

  • 3. α-Lipoic acid inhibits human lung cancer cell proliferation through Grb2-mediated EGFR downregulation.
    Yang L; Wen Y; Lv G; Lin Y; Tang J; Lu J; Zhang M; Liu W; Sun X
    Biochem Biophys Res Commun; 2017 Dec; 494(1-2):325-331. PubMed ID: 28993193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Notch signaling mediates G1/S cell-cycle progression in T cells via cyclin D3 and its dependent kinases.
    Joshi I; Minter LM; Telfer J; Demarest RM; Capobianco AJ; Aster JC; Sicinski P; Fauq A; Golde TE; Osborne BA
    Blood; 2009 Feb; 113(8):1689-98. PubMed ID: 19001083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The CDK4/CDK6 inhibitor PD0332991 paradoxically stabilizes activated cyclin D3-CDK4/6 complexes.
    Paternot S; Colleoni B; Bisteau X; Roger PP
    Cell Cycle; 2014; 13(18):2879-88. PubMed ID: 25486476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lineage specific composition of cyclin D-CDK4/CDK6-p27 complexes reveals distinct functions of CDK4, CDK6 and individual D-type cyclins in differentiating cells of embryonic origin.
    Bryja V; Pacherník J; Vondráček J; Souček K; Čajánek L; Horvath V; Holubcová Z; Dvořák P; Hampl A
    Cell Prolif; 2008 Dec; 41(6):875-893. PubMed ID: 19040567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclin D3 maintains growth-inhibitory activity of C/EBPalpha by stabilizing C/EBPalpha-cdk2 and C/EBPalpha-Brm complexes.
    Wang GL; Shi X; Salisbury E; Sun Y; Albrecht JH; Smith RG; Timchenko NA
    Mol Cell Biol; 2006 Apr; 26(7):2570-82. PubMed ID: 16537903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fangchinoline induces G1 arrest in breast cancer cells through cell-cycle regulation.
    Xing Z; Zhang Y; Zhang X; Yang Y; Ma Y; Pang D
    Phytother Res; 2013 Dec; 27(12):1790-4. PubMed ID: 23401195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclin A but not cyclin D1 is essential for c-myc-modulated cell-cycle progression.
    Qi Y; Tu Y; Yang D; Chen Q; Xiao J; Chen Y; Fu J; Xiao X; Zhou Z
    J Cell Physiol; 2007 Jan; 210(1):63-71. PubMed ID: 17013808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The metabolic function of cyclin D3-CDK6 kinase in cancer cell survival.
    Wang H; Nicolay BN; Chick JM; Gao X; Geng Y; Ren H; Gao H; Yang G; Williams JA; Suski JM; Keibler MA; Sicinska E; Gerdemann U; Haining WN; Roberts TM; Polyak K; Gygi SP; Dyson NJ; Sicinski P
    Nature; 2017 Jun; 546(7658):426-430. PubMed ID: 28607489
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting cyclin-dependent kinase 1 (CDK1) but not CDK4/6 or CDK2 is selectively lethal to MYC-dependent human breast cancer cells.
    Kang J; Sergio CM; Sutherland RL; Musgrove EA
    BMC Cancer; 2014 Jan; 14():32. PubMed ID: 24444383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amniotic membrane-derived cells inhibit proliferation of cancer cell lines by inducing cell cycle arrest.
    Magatti M; De Munari S; Vertua E; Parolini O
    J Cell Mol Med; 2012 Sep; 16(9):2208-18. PubMed ID: 22260183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phospholipase C delta 1 regulates cell proliferation and cell-cycle progression from G1- to S-phase by control of cyclin E-CDK2 activity.
    Kaproth-Joslin KA; Li X; Reks SE; Kelley GG
    Biochem J; 2008 Nov; 415(3):439-48. PubMed ID: 18588506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutually exclusive cyclin-dependent kinase 4/cyclin D1 and cyclin-dependent kinase 6/cyclin D2 pairing inactivates retinoblastoma protein and promotes cell cycle dysregulation in multiple myeloma.
    Ely S; Di Liberto M; Niesvizky R; Baughn LB; Cho HJ; Hatada EN; Knowles DM; Lane J; Chen-Kiang S
    Cancer Res; 2005 Dec; 65(24):11345-53. PubMed ID: 16357141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. cAMP-mediated growth inhibition of lymphoid cells in G1: rapid down-regulation of cyclin D3 at the level of translation.
    Naderi S; Gützkow KB; Christoffersen J; Smeland EB; Blomhoff HK
    Eur J Immunol; 2000 Jun; 30(6):1757-68. PubMed ID: 10898514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retinoic acid-mediated growth arrest of EBV-immortalized B lymphocytes is associated with multiple changes in G1 regulatory proteins: p27Kip1 up-regulation is a relevant early event.
    Zancai P; Cariati R; Rizzo S; Boiocchi M; Dolcetti R
    Oncogene; 1998 Oct; 17(14):1827-36. PubMed ID: 9778049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin-like growth factor binding protein-3 induces G1 cell cycle arrest with inhibition of cyclin-dependent kinase 2 and 4 in MCF-7 human breast cancer cells.
    Kim HS; Lee WJ; Lee SW; Chae HW; Kim DH; Oh Y
    Horm Metab Res; 2010 Mar; 42(3):165-72. PubMed ID: 19960406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of cyclin-dependent kinase-2 induces apoptosis in human diffuse large B-cell lymphomas.
    Faber AC; Chiles TC
    Cell Cycle; 2007 Dec; 6(23):2982-9. PubMed ID: 18156799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A vitamin D3 analog induces a G1-phase arrest in CaCo-2 cells by inhibiting cdk2 and cdk6: roles of cyclin E, p21Waf1, and p27Kip1.
    Scaglione-Sewell BA; Bissonnette M; Skarosi S; Abraham C; Brasitus TA
    Endocrinology; 2000 Nov; 141(11):3931-9. PubMed ID: 11089522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. G1 arrest of U937 cells by onconase is associated with suppression of cyclin D3 expression, induction of p16INK4A, p21WAF1/CIP1 and p27KIP and decreased pRb phosphorylation.
    Juan G; Ardelt B; Li X; Mikulski SM; Shogen K; Ardelt W; Mittelman A; Darzynkiewicz Z
    Leukemia; 1998 Aug; 12(8):1241-8. PubMed ID: 9697879
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.